Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study Testing the Superiority of CHF 1535 pMDI 800/24µg Total Daily Dose Compared With CHF 718 pMDI 800µg Total Daily Dose in Adults With Asthma on Medium or High-Dose Inhaled Corticosteroid

ClinicalTrials.gov ID: NCT05292586

Public ClinicalTrials.gov record NCT05292586. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 2:55 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 12 Week, Randomized, Double-blind, Multicenter, Active Controlled, 2-Arm Parallel Group Study Testing the Superiority of CHF 1535 pMDI 800/24µg Total Daily Dose (Fixed Combination of Extrafine Beclomethasone Dipropionate Plus Formoterol Fumarate) Compared to CHF 718 pMDI 800µg Total Daily Dose (Extrafine Beclomethasone Dipropionate) in Adults With Asthma on Medium or High-Dose Inhaled Corticosteroid

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Compare the superiority of CHF 1535 versus CHF 718 in subjects with asthma who are on medium or high dose inhaled corticosteroids.

Study identification

NCT ID
NCT05292586
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Chiesi Farmaceutici S.p.A.
Industry
Enrollment
1,377 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2022 (Actual)
Primary completion
Jun 24, 2024 (Actual)
Completion
Jun 24, 2024 (Actual)
Last update posted
Jul 20, 2026

2022 – 2024

United States locations

U.S. sites
91
U.S. states
23
U.S. cities
68
Facility City State ZIP Site status
Chiesi Clinical Trial Site 840858 Mobile Alabama 36608 —
Chiesi Clinical Trial Site 840895 Chandler Arizona 85224 —
Chiesi Clinical Trial Site 840856 Encinitas California 92024 —
Chiesi Clinical Trial Site 840843 Huntington Beach California 92647 —
Chiesi Clinical Trial Site 840860 Huntington Beach California 92647 —
Chiesi Clinical Trial Site 840896 Long Beach California 90805 —
Chiesi Clinical Trial Site 840883 Los Angeles California 90025 —
Chiesi Clinical Trial Site 840810 Los Angeles California 90048 —
Chiesi Clinical Trial Site 840869 Newport Beach California 92663 —
Chiesi Clinical Trial Site 840890 North Hollywood California 91606 —
Chiesi Clinical Trial Site 840808 Northridge California 91324 —
Chiesi Clinical Trial Site 840879 Pomona California 91768 —
Chiesi Clinical Trial Site 840868 Sacramento California 95823 —
Chiesi Clinical Trial Site 840849 San Diego California 92120 —
Chiesi Clinical Trial Site 840877 San Diego California 92123 —
Chiesi Clinical Trial Site 840861 San Jose California 95117 —
Chiesi Clinical Trial Site 840881 Westminster California 92683 —
Chiesi Clinical Trial Site 840873 Colorado Springs Colorado 80907 —
Chiesi Clinical Trial Site 840800 Denver Colorado 80230 —
Chiesi Clinical Trial Site 840820 Coral Gables Florida 33134 —
Chiesi Clinical Trial Site 840841 Cutler Bay Florida 33189 —
Chiesi Clinical Trial Site 840817 Greenacres City Florida 33467 —
Chiesi Clinical Trial Site 840822 Hialeah Florida 33012 —
Chiesi Clinical Trial Site 840838 Hialeah Florida 33015 —
Chiesi Clinical Trial Site 840864 Kissimmee Florida 34746 —
Chiesi Clinical Trial Site 840814 Miami Florida 33125 —
Chiesi Clinical Trial Site 840819 Miami Florida 33126 —
Chiesi Clinical Trial Site 840875 Miami Florida 33126 —
Chiesi Clinical Trial Site 840887 Miami Florida 33134 —
Chiesi Clinical Trial Site 840821 Miami Florida 33136 —
Chiesi Clinical Trial Site 840829 Miami Florida 33155 —
Chiesi Clinical Trial Site 840828 Miami Florida 33165 —
Chiesi Clinical Trial Site 840847 Miami Florida 33172 —
Chiesi Clinical Trial Site 840818 Miami Florida 33174 —
Chiesi Clinical Trial Site 840802 Miami Florida 33176 —
Chiesi Clinical Trial Site 840835 Miami Florida 33184 —
Chiesi Clinical Trial Site 840806 Miami Florida 33185 —
Chiesi Clinical Trial Site 840855 Miami Florida 33186 —
Chiesi Clinical Trial Site 840809 Miami Gardens Florida 33014 —
Chiesi Clinical Trial Site 840863 Miami Lakes Florida 33014 —
Chiesi Clinical Trial Site 840865 Miami Lakes Florida 33014 —
Chiesi Clinical Trial Site 840831 Miami Springs Florida 33166 —
Chiesi Clinical Trial Site 840839 Palmetto Bay Florida 33157 —
Chiesi Clinical Trial Site 840840 Pembroke Pines Florida 33024 —
Chiesi Clinical Trial Site 840827 Pembroke Pines Florida 33029 —
Chiesi Clinical Trial Site 840811 Port Saint Lucie Florida 34952 —
Chiesi Clinical Trial Site 840889 St. Petersburg Florida 33707 —
Chiesi Clinical Trial Site 840834 St. Petersburg Florida 33709 —
Chiesi Clinical Trial Site 840880 St. Petersburg Florida 33713 —
Chiesi Clinical Trial Site 840807 Tallahassee Florida 32308 —
Chiesi Clinical Trial Site 840871 Adairsville Georgia 30103 —
Chiesi Clinical Trial Site 840824 White Marsh Maryland 21162 —
Chiesi Clinical Trial Site 840826 North Dartmouth Massachusetts 02747 —
Chiesi Clinical Trial Site 840859 Columbia Missouri 65203 —
Chiesi Clinical Trial Site 840888 Saint Charles Missouri 63301 —
Chiesi Clinical Trial Site 840846 St Louis Missouri 63141 —
Chiesi Clinical Trial Site 840867 Bellevue Nebraska 68123 —
Chiesi Clinical Trial Site 840897 Henderson Nevada 89052 —
Chiesi Clinical Trial Site 840872 North Las Vegas Nevada 89030 —
Chiesi Clinical Trial Site 840836 Brick New Jersey 08724 —
Chiesi Clinical Trial Site 840851 Albuquerque New Mexico 87108 —
Chiesi Clinical Trial Site 840899 Monroe North Carolina 28112 —
Chiesi Clinical Trial Site 840852 Raleigh North Carolina 27607 —
Chiesi Clinical Trial Site 840866 Edmond Oklahoma 73034 —
Chiesi Clinical Trial Site 840878 Tulsa Oklahoma 74133 —
Chiesi Clinical Trial Site 840884 Grants Pass Oregon 97527 —
Chiesi Clinical Trial Site 840830 Medford Oregon 97504 —
Chiesi Clinical Trial Site 840853 Portland Oregon 97202 —
Chiesi Clinical Trial Site 840885 Warwick Rhode Island 02886 —
Chiesi Clinical Trial Site 840892 Anderson South Carolina 29621 —
Chiesi Clinical Trial Site 840844 Columbia South Carolina 29204 —
Chiesi Clinical Trial Site 840850 Greenville South Carolina 29615 —
Chiesi Clinical Trial Site 840894 Rock Hill South Carolina 29732 —
Chiesi Clinical Trial Site 840891 Spartanburg South Carolina 29303 —
Chiesi Clinical Trial Site 840812 Knoxville Tennessee 37909 —
Chiesi Clinical Trial Site 840815 Baytown Texas 77521 —
Chiesi Clinical Trial Site 840874 Boerne Texas 78006 —
Chiesi Clinical Trial Site 840845 Carrollton Texas 75007 —
Chiesi Clinical Trial Site 840876 Dallas Texas 75225 —
Chiesi Clinical Trial Site 840803 El Paso Texas 79903 —
Chiesi Clinical Trial Site 840833 Houston Texas 77094 —
Chiesi Clinical Trial Site 840862 McKinney Texas 75069 —
Chiesi Clinical Trial Site 840816 McKinney Texas 75071 —
Chiesi Clinical Trial Site 840842 San Antonio Texas 78207 —
Chiesi Clinical Trial Site 840857 San Antonio Texas 78215 —
Chiesi Clinical Trial Site 840823 San Antonio Texas 78258 —
Chiesi Clinical Trial Site 840801 Sugar Land Texas 77479 —
Chiesi Clinical Trial Site 840893 Murray Utah 84107 —
Chiesi Clinical Trial Site 840837 Riverton Utah 84065 —
Chiesi Clinical Trial Site 840882 Bellingham Washington 98225 —
Chiesi Clinical Trial Site 840870 Greenfield Wisconsin 53228 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05292586, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 20, 2026 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05292586 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →